RAPP vs HAWK
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
RAPP · Rapport Therapeutics$24.44 ▲ 3.04%
HAWK · HawkEye 360$14.79 ▲ 15.91%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- RAPP -38.8%
- HAWK -56.5%
Head to head
| Metric | RAPP | HAWK |
|---|---|---|
| Price | $24.44 | $14.79 |
| Change today | ▲ 3.04% | ▲ 15.91% |
| Market cap | $1.45B | $1.45B |
| Return, 3 months | -48.0% | -41.3% |
| Return, year to date | -19.4% | – |
| Return, 1 year | -4.8% | – |
| P/E (TTM) | -7.7 | -113.8 |
| P/B | 3.7 | 1.8 |
| P/E percentile vs own 5y | 73rd | 60th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | +87.1% |
| Net profit growth (YoY) | -111.8% | -1,048.4% |
| Gross margin | – | 50.2% |
| Operating margin | -767.6% | -15.5% |
| Net margin | -685.8% | -10.1% |
| Return on equity | -40.0% | -2.9% |
| Analyst target vs. price | +184.0% | +71.9% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 38 | 56 |
| 30-day volatility | 95.7% | 73.9% |
| Max drawdown, 1 year | -57.1% | -66.3% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- HAWK is the largest of the group by market value.
- HAWK carries the lowest trailing P/E.
- HAWK keeps the most profit per dollar of sales.
- HAWK has been the calmest stock over the last 30 days.